Leverage big data and quantum-based AI to accelerate lead discovery with higher accuracy.
GeneOn Biotech integrates large-scale protein microarray data (21,000 proteins, 200,000 peptides) with cutting-edge AI algorithms (Graph Neural Network, MPNN, RF Diffusion, AlphaFold) and quantum optimization (VQE, QAOA) to significantly accelerate drug discovery.
Large-scale data collection via protein/peptide microarrays
Target candidate prediction using GNN, MPNN models
Binding energy & stability optimization using VQE/QAOA
Candidate validation via Human Protein Array & Epitope Mapping
Target Prediction &
Lead Screening
Epitope Mapping
(200K Peptide Array)
Off-Target Assessment
(Human Protein Array)
Custom AI Model
Development
| Category | Traditional | GeneOn AI Platform |
|---|---|---|
| Timeline | Several months | Few weeks |
| Cost | High | ~70% reduction |
| Scale | Hundreds of proteins | Thousands to tens of thousands |
AI design → Peptide mapping → Human Protein Array validation with successful results.
• Publications: Nature STTT (Elixiah PoC, etc.)
• Patents pending (candidate process related)
• Internal QC procedures & reproducibility metrics available
ENGLISH
